InVivoMAb anti-mouse IL-27 p28

Ayasoufi K, Zwick DB, Fan R, et al. Interleukin-27 promotes CD8+ T cell reconstitution following antibody-mediated lymphoablation. JCI Insight. 2019,4(7):pii: 125489. doi: 10.1172/jci.insight.125489.

Xin G, Zander R, Schauder DM, et al. Single-cell RNA sequencing unveils an IL-10-producing helper subset that sustains humoral immunity during persistent infection. Nat Commun. 2018,9(1):5037. doi: 10.1038/s41467-018-07492-4

Clement M, Marsden M, Stacey MA, et al. Cytomegalovirus-Specific IL-10-Producing CD4+ T Cells Are Governed by Type-I IFN-Induced IL-27 and Promote Virus Persistence. PLoS Pathog. 2016,12(12):e1006050. doi: 10.1371/journal.ppat.1006050

Anderson AC, Sullivan JM, Tan DJ, et al. A T cell extrinsic mechanism by which IL-2 dampens Th17 differentiation. J Autoimmun. 2015,59:38-42. doi: 10.1016/j.jaut.2015.02.001

Marillier RG, Uyttenhove C, Goriely S, et al. IL-27p28 is essential for parent-to-F1 acute graft-versus-host disease. Eur J Immunol. 2014,44(7):2064-73. doi: 10.1002/eji.201444491

Bosmann M, Strobl B, Kichler N, et al. Tyrosine kinase 2 promotes sepsis-associated lethality by facilitating production of interleukin-27. J Leukoc Biol. 2014,96(1):123-31. doi: 10.1189/jlb.3A1013-541R